More on incy
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $128.00 |
|
|||
| Open | $126.46 | ||||
| 52 Wk High | $118.49 | ||||
| 52 Wk Low | $55.00 | ||||
| Day High | $128.08 | ||||
| Day Low | $126.04 | ||||
| P/E | N/A | ||||
| EPS | $-0.56 | ||||
| Volume | 1,035,974 | ||||
- Incyte to Present at Upcoming Investor Conferences
- H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
- BMO Capital Reiterates Market Perform Rating on Incyte (INCY)
- Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil
- Form 4 INCYTE CORP For: Aug 25 Filed by: Basi Ramitpal K
- H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
- TD Cowen Assumes Incyte (INCY) at Buy
- Form 4 INCYTE CORP For: Aug 19 Filed by: CAGNONI PABLO J
- Canaccord Starts Incyte (INCY) at Buy
- H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
Entities mentioned with INCY
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
